US Patent Issued to University of Florida Research Foundation on Nov. 3 for "AAV cardiac gene therapy for cardiomyopathy in humans" (Florida Inventor)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,051, issued on Nov. 3, was assigned to University of Florida Research Foundation Inc. (Gainesville, Fla.).

"AAV cardiac gene therapy for cardiomyopathy in humans" was invented by Hugh Lee Sweeney (Gainesville, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compositions and methods useful in treating heart conditions. The disclosed compositions and methods encompass gene therapies including a recombinant AAV vector for delivering two or more transgenes into the heart of a human subject. The two or more transgenes comprise an S100A1 protein and a cardiac Apoptosis Repressor with Caspase Recruitment Domain (cARC) apo...